Pesquisas alternativas:
development type » development types (Expandir a Pesquisa), development time (Expandir a Pesquisa), development three (Expandir a Pesquisa)
dose developing » mouse developing (Expandir a Pesquisa), those developing (Expandir a Pesquisa), de developing (Expandir a Pesquisa)
developed open » developed over (Expandir a Pesquisa), development open (Expandir a Pesquisa), developing open (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
drug de » drug dna (Expandir a Pesquisa)
A mostrar 1 - 20 resultados de 62 para a pesquisa '(( drug de ((development type) or (developed open)) ) or ( drug dose developing type ))', tempo de pesquisa: 1.36seg Refinar resultados
Dose‐Finding Studies Among Orphan Drugs Approved in the EU: A Retrospective Analysis
Metformin causes a futile intestinal–hepatic cycle which increases energy expenditure and slows down development of a type 2 diabetes-like state

Previous spatial learning is required for the development of place preference in rats following chronic administration of and withdrawal from morphine
Identification and Assessment of Adherence-Enhancing Interventions in Studies Assessing Medication Adherence Through Electronically Compiled Drug Dosing Histories: A Systematic Literature Review and Meta-Analysis

Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus
Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial

Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?
The Costs and Cost-Effectiveness of Mass Treatment for Intestinal Nematode Worm Infections Using Different Treatment Thresholds

7th drug hypersensitivity meeting: part one
In vivo chemotherapeutic insight of a novel isocoumarin (3-hexyl-5,7-dimethoxy-isochromen-1-one): Genotoxicity, cell death induction, leukometry and phagocytic evaluation

Delirium risk screening and haloperidol prophylaxis program in hip fracture patients is a helpful tool in identifying high-risk patients, but does not reduce the incidence of delirium
MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR–TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Risk Factor Evaluation for Individualized Treatment Need of Ranibizumab or Aflibercept According to an Observe-and-Plan Regimen

Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors
A multicenter open-label treatment protocol (HGT-GCB-058) of velaglucerase alfa enzyme replacement therapy in patients with Gaucher disease type 1: safety and tolerability

Costs and benefits of bevacizumab vial sharing for the treatment of retinal diseases
Herpes simplex virus: isolation, cytopathological characterization and antiviral sensitivity()

Novel SGLT2 inhibitor: first‐in‐man studies of antisense compound is associated with unexpected renal effects
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials

FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system
STatistically Assigned Response Criteria in Solid Tumors (STARCIST)

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa